Anguita Sánchez M, Crespo Leiro MG, de Teresa GE, Jiménez Navarro M, Alonso Pulpón L, Muñiz García J et al (2008) Prevalence of heart failure in Spanish general population aged over 45 years. The PRICE study. Rev Esp Cardiol 61:1041–1049
Groenewegen A, Rutter FH, Mosterd A, Hoes AW (2020) Epidemiology of heart failure. Eur J Heart Fail 22:1342–1356
Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP et al (2017) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced dejection fraction: an analysis of the ESC heart failure lon-term registry. Eur J Heart Fail 19:1574–1585
Article CAS PubMed Google Scholar
Maggioni AP, Anker SD, Dahlstrom U, Filipattos G, Ponikowski P, Zannad F et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with ESC guidelines? Evidence from 12440 patients of the ESC Heart failure long-term registry. Eur J Heart Fail 15:1173–1184
Article CAS PubMed Google Scholar
Bonilla Palomas JL, Anguita Sánchez MM, Elola Somoza FJ, Bernal Sobrino JL, Fernández Pérez C, Ruiz Ortiz M et al (2021) Thirteen-year trends in hospitalization and outcomes of patients with heart failure in Spain. Eur J Clin Invest 51:e13606
Anguita SM, Bonilla Palomas JL, García Márquez M, Bernal Sobrino JL, Elola Somoza FJ, Marin Ortuño F (2020) Temporal trends in hospitalizations and in-hospital mortality in heart failure in Spain 2003–2015: differences between autonomous communities. Rev Esp Cardiol 73:1075–1077
Maggioni AP, Anker SD, Dahlstrom U, Filippatos G, Ponikowski P, Zannad F et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with ESC guidelines? Evidence from 12.440 patients of the ESC heart failure long-term registry. Eur J Heart Fail 15:1173–1184
Article CAS PubMed Google Scholar
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2023) 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 44:3627–3639
Article CAS PubMed Google Scholar
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al (2016) 2010 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726
Article CAS PubMed Google Scholar
Kaplon-Cieslicka A, Benson L, Chioncel O, Crespo-Leiro MG, Coats AJS, Anker SD et al (2022) A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction. Insights from the ESC-HFA EORP heart failure long-term registry. Eur J Heart Fail 24:335–350
Article CAS PubMed Google Scholar
Anguita Sánchez M, Recio Mayoral A, Rodríguez PL (2024) Improving the quality of health care. Results of the SEC-excelente accreditation program in heart failure of the Spanish society of cardiology. Rev Esp Cardiol. https://doi.org/10.1016/j.recesp2024.02.001
Savarese G, Becher PM, Lund L, Seferovic P, Rosano GMC, Coats AJS (2022) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118:3272–3287
Seferovic PM, Vardas P, Jankowska EA, Maggioni A, Timmis A, Milinkovic I et al (2021) The heart failure association Atlas: heart failure epidemiology and management statistics 2019. Eur J Heart Fail 23:906–914
Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Crespo-Leiro MG, Drozdz J et al (2013) EURObservational research programme: regional differences and 1-year follow-up results of the heart failure pilot survey (ESC-HF Pilot). Eur J Heart Fail 15:808–817
Pabon M, Cunnigham J, Claggett B, Felker GM, McMurray JJV, Metra M et al (2023) Sex differences in heart failure with reduced ejection fraction in the GALACTIC-HF trial. JACC Heart Fail 11:1729–1738
Article CAS PubMed Google Scholar
Schmidt M, Ulrichsen SP, Pedersen L, Botker HE, Sorensen HT (2016) Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of comorbidity: a Danish nation-wide cohort study. Eur J Heart Fail 18:490–499
Conrad N, Judge A, Canoy D, Tran J, Pinho-Gomes AC, Millett ERC et al (2019) Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86000 individuals. JAMA Cardiol 4:1102–1111
Article PubMed PubMed Central Google Scholar
Esteban-Fernández A, Anguita-Sánchez M, Bonilla-Palomas JL, Anguita Gámez M, Rosillo N, Del Prado N et al (2023) One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public hospitals in Spain between 2016 and 2018. Clin Res Cardiol 112:1119–1128
Packer M, Anker SD, Buttler J, Filippatos G, Pocock SJ, Carlson P et al (2020) Cardiovascular and renal outcomes with empaglifozin in heart failure. N Eng J Med 383:1413–1424
McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA et al (2019) Dapaglifozin in patients with heart failure and reduced ejection fraction. N Eng J Med 381:1995–2008
Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M et al (2021) Empaglifozin in heart failure with a preserved ejection fraction. N Eng J Med 385:1451–1461
Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMetts D, Hernandez AF et al (2022) Dapaglifozin in heart failure with mildly reduced or preserved ejection fraction. N Eng J Med 387:1089–1098
Savarese G, Vedin O, D’Armario D, Ujil A, Dahlstrom U, Rosano G et al (2019) Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. JACC Heart Fail 7:306–317
Comments (0)